Cargando…

Economic burden of sickle cell disease in Brazil

BACKGROUND: Sickle cell disease (SCD) may cause several impacts to patients and the whole society. About 4% of the population has the sickle cell trait in Brazil, and 60,000 to 100,000 have SCD. However, despite recognizing the significant burden of disease, little is known about SCD costs. OBJECTIV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva-Pinto, Ana Cristina, Costa, Fernando F., Gualandro, Sandra Fatima Menosi, Fonseca, Patricia Belintani Blum, Grindler, Carmela Maggiuzzu, Souza Filho, Homero C. R., Bueno, Carolina Tosin, Cançado, Rodolfo D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202914/ https://www.ncbi.nlm.nih.gov/pubmed/35709301 http://dx.doi.org/10.1371/journal.pone.0269703

Ejemplares similares

Estimated mortality rates of individuals with sickle cell disease in Brazil: real-world evidence
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2023)

Non-Cardiac Surgery in Developing Countries: Epidemiological Aspects and Economical Opportunities – The Case of Brazil
por: Yu, Pai Ching, et al.
Publicado: (2010)

Infectious complications after surgical splenectomy in children with sickle cell disease
por: Monaco, Cypriano Petrus, et al.
Publicado: (2015)

Characteristics of paroxysmal nocturnal hemoglobinuria patients in Brazil: A retrospective administrative claims database analysis of PNH patients in Brazilian public healthcare system
por: Menosi Gualandro, Sandra Fatima, et al.
Publicado: (2023)

Paraoxonases (PON) 1, 2, and 3 Polymorphisms and PON-1 Activities in Patients with Sickle Cell Disease
por: Reichert, Cadiele Oliana, et al.
Publicado: (2019)

Quality of life scores differs between genotypic groups of patients with suspected hereditary hemochromatosis
por: Fonseca, Paula Fernanda Silva, et al.
Publicado: (2018)

Sickle cell disease: looking back but towards the future
por: Cançado, Rodolfo Delfini
Publicado: (2012)

Guidelines on the treatment of anemia of chronic renal failure using recombinant human erythropoietin: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira – 2014
por: da Silva Araújo, Aderson, et al.
Publicado: (2014)

Comprehensive healthcare for individuals with sickle cell disease - a constant challenge
por: Cançado, Rodolfo Delfini
Publicado: (2011)

Brazilian Guidelines for transcranial doppler in children and adolescents with sickle cell disease
por: Lobo, Clarisse Lopes de Castro, et al.
Publicado: (2011)

Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria
por: Cançado, Rodolfo D., et al.
Publicado: (2021)

Acute Chest Syndrome in Pregnant Women with Hemoglobin SC Disease
por: Nomura, Roseli Mieko Yamamoto, et al.
Publicado: (2009)

Health and Economic Burden of Obesity in Brazil
por: Rtveladze, Ketevan, et al.
Publicado: (2013)

The Economic Burden of Heart Conditions in Brazil
por: Stevens, Bryce, et al.
Publicado: (2018)

Economic burden of diabetes in Brazil in 2014
por: Bahia, Luciana Ribeiro, et al.
Publicado: (2019)

Mortality by sickle cell disease in Brazil
por: Arduini, Giovanna Abadia Oliveira, et al.
Publicado: (2017)

The economic impact of asthma on private healthcare system in Brazil: Economic impact of asthma in Brazil
por: Nascimento, Oliver A., et al.
Publicado: (2023)

Risk factors for deferral due to low hematocrit and iron depletion among prospective blood donors in a Brazilian center
por: Dauar, Eloísa Tedeschi, et al.
Publicado: (2015)

Real-World Evidence on Disease Burden and Economic Impact of Sickle Cell Disease in Italy
por: De Franceschi, Lucia, et al.
Publicado: (2022)

The Economic Burden of HIV/AIDS and Myocardial Infarction Treatment in Brazil
por: Araújo, Denizar Vianna, et al.
Publicado: (2013)

The economic burden of congenital Zika Syndrome in Brazil: an overview at 5 years and 10 years
por: Fernandes, Silke, et al.
Publicado: (2022)

Maternal and perinatal outcomes in pregnant women with sickle cell disease: an update
por: Sousa, Viviane Teixeira de, et al.
Publicado: (2022)

Evaluation of renal function in sickle cell disease patients in Brazil
por: Silva Junior, G.B., et al.
Publicado: (2012)

P1704: PROJECTED LIFETIME ECONOMIC BURDEN OF SEVERE SICKLE CELL DISEASE IN THE UNITED STATES
por: Udeze, C., et al.
Publicado: (2022)

The XmnI polymorphic site 5’ to the gene G(γ) in a Brazilian patient with sickle cell anaemia – fetal haemoglobin concentration, haematology and clinical features
por: Belini Júnior, Édis, et al.
Publicado: (2010)

Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States
por: Udeze, Chuka, et al.
Publicado: (2023)

The Neonatal Screening Program in Brazil, Focus on Sickle Cell Disease (SCD)
por: Silva-Pinto, Ana C., et al.
Publicado: (2019)

Economic Burden of Cardiovascular Diseases in Brazil: Are Telemedicine and Structured Telephone Support the Solution?
por: da Silva, Suzana Alves, et al.
Publicado: (2018)

Economic burden of colorectal and breast cancers attributable to lack of physical activity in Brazil
por: Rezende, Leandro F. M., et al.
Publicado: (2021)

O-04: INCIDENCE OF VASO-OCCLUSIVE CRISES IN PATIENTS WITH SICKLE CELL DISEASE (SCD) AND A HIGH BASELINE DISEASE BURDEN TREATED WITH CRIZANLIZUMAB IN A REAL-WORLD SETTING: RESULTS FROM A MANAGED ACCESS PROGRAM (MAP)
por: A., SILVA-PINTO, et al.
Publicado: (2022)

Dental care provided to sickle cell anemia patients stratified by age: A population-based study in Northeastern Brazil
por: Costa, Cyrene Piazera Silva, et al.
Publicado: (2016)

Patient-Reported Outcomes and Economic Burden of Adults with Sickle Cell Disease in the United States: A Systematic Review
por: Lee, Soyon, et al.
Publicado: (2020)

Correction to: Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States
por: Udeze, Chuka, et al.
Publicado: (2023)

P1491: REAL-WORLD INCIDENCE OF VASO-OCCLUSIVE CRISES IN PATIENTS WITH SICKLE CELL DISEASE (SCD) AND A HIGH BASELINE DISEASE BURDEN TREATED WITH CRIZANLIZUMAB: RESULTS FROM A MANAGED ACCESS PROGRAM (MAP)
por: Silva-Pinto, A. C., et al.
Publicado: (2022)

Non-indolent mantle cell lymphoma at a single public hospital in Brazil: real world first-line treatment cohort study data
por: Brasil, Sergio Augusto Buzian, et al.
Publicado: (2020)

The influence of hydroxyurea on oxidative stress in sickle cell anemia
por: Torres, Lidiane de Souza, et al.
Publicado: (2012)

Erratum on “Non-indolent mantle cell lymphoma at a single public hospital in Brazil: real world first-line treatment cohort study data”
por: Brasil, Sergio Augusto Buzian, et al.
Publicado: (2020)

Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study
por: Shah, Nirmish, et al.
Publicado: (2019)

Long-term monitoring of SARS-COV-2 RNA in wastewater in Brazil: A more responsive and economical approach
por: Claro, Ieda Carolina Mantovani, et al.
Publicado: (2021)

Association between firearms and mortality in Brazil, 1990 to 2017: a global burden of disease Brazil study
por: Malta, Deborah Carvalho, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rklk6jegao6mec9or8ekdgq36p